# Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

> **NCT01390857** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 379 (actual)

## Conditions studied

- Varicella

## Interventions

- **DRUG:** Valaciclovir

## Key facts

- **NCT ID:** NCT01390857
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-09
- **Final completion:** 2010-05
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390857, "Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01390857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*